Dr. Peter Nelson, an investigator in the Human Biology and Clinical Research divisions, will take part in a prostate-cancer research consortium led by the Winship Cancer Institute at Emory University.
Nelson represents Fred Hutchinson as one of 13 research institutions in the $10 million, three-year project funded by the U.S. Department of Defense Prostate Cancer Research Program. The project's goal is to identify new therapeutic targets and concepts for effective treatment of advanced prostate cancer.
More than 20 institutions applied for the $150,000 first-phase planning grants. From those, five were chosen by the Department of Defense to compete for the final consortium award, dubbed the "Manhattan Project" of prostate cancer.
Participants will employ Web-based videoconferencing, real-time online video-streaming and data-sharing technologies.
The Nelson lab will focus on the development of a molecular grading system for prostate cancer with the objective of providing improved prognostic information as well as stratifying patients for targeted clinical trials.